106 related articles for article (PubMed ID: 15358120)
1. Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity.
Liu W; Sun M; Jiang J; Shen X; Sun Q; Liu W; Shen H; Gu J
Biochem Biophys Res Commun; 2004 Sep; 321(4):954-60. PubMed ID: 15358120
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D3 interacts with vitamin D receptor and regulates its transcription activity.
Jian Y; Yan J; Wang H; Chen C; Sun M; Jiang J; Lu J; Yang Y; Gu J
Biochem Biophys Res Commun; 2005 Sep; 335(3):739-48. PubMed ID: 16105657
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.
Lazaro JB; Bailey PJ; Lassar AB
Genes Dev; 2002 Jul; 16(14):1792-805. PubMed ID: 12130539
[TBL] [Abstract][Full Text] [Related]
4. A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.
Arsenijevic T; Degraef C; Dumont JE; Roger PP; Pirson I
Biochem J; 2004 Mar; 378(Pt 2):673-9. PubMed ID: 14641107
[TBL] [Abstract][Full Text] [Related]
5. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo.
Sun W; Lee DK; Lee CC; Kim K
Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
11. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
12. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
Ando K; Griffin JD
Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
14. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation.
Mukhopadhyay A; Banerjee S; Stafford LJ; Xia C; Liu M; Aggarwal BB
Oncogene; 2002 Dec; 21(57):8852-61. PubMed ID: 12483537
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF.
Voit R; Hoffmann M; Grummt I
EMBO J; 1999 Apr; 18(7):1891-9. PubMed ID: 10202152
[TBL] [Abstract][Full Text] [Related]
17. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
18. Identification of the p28 subunit of eukaryotic initiation factor 3(eIF3k) as a new interaction partner of cyclin D3.
Shen X; Yang Y; Liu W; Sun M; Jiang J; Zong H; Gu J
FEBS Lett; 2004 Aug; 573(1-3):139-46. PubMed ID: 15327989
[TBL] [Abstract][Full Text] [Related]
19. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
Johnson DG
Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
[TBL] [Abstract][Full Text] [Related]
20. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
